AORT Artivion, Inc. Common Stock
$29,85
Cena · Sie 19, 2026
Dane fundamentalne na dzień Sie 7, 2026
Zakres 52 tyg.
$19–$48
37% of range
Ocena Analityków
BUY
14 analysts
Cena Docelowa
$42
+41% upside
P/E (TTM)
144.0
ROE
2.2%
Marża Zysku Netto
2.2%
O Artivion, Inc. Common Stock Przegląd firmy z Wikipedii
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.
Czytaj więcej
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.
## History
Artivion was founded as CryoLife in Sarasota, Florida in 1984 by Steven Anderson and Robert McNally. Anderson acted as the company’s president and CEO from its founding. The company later moved from Sarasota to the Atlanta metropolitan area. In January 2022 the company changed its name to Artivion, Inc.
In 2000, CryoLife began offering a surgical adhesive called BioGlue used for sealing surgical lacerations under high pressure, such as in arteries.
In February 2008, the FDA gave CryoLife approval for a new kind of heart valve, made from human tissues, which was the first to remove cells from the transplant tissue as opposed to only cleaning the tissue. In giving the approval, the FDA said the new valve, called the CryoValve SynerGraft Pulmonary Valve, had less of a chance of rejection than previous valves.
In 2010, CryoLife acquired the rights to manufacture and distribute PerClot, an absorbable hemostatic powder used in surgery.
In January 2016, the company acquired On-X Life Technologies and its principal product, a mechanical heart valve called the On-X aortic valve replacement, for $130 million.
In October 2017, Artivion acquired JOTEC GmbH, a German-based developer of medical devices for aortic and peripheral vascular diseases, for €225 million. In September 2020, the company acquired Ascyrus Medical.
In 2021, the company received FDA premarket application approval of its PerClot absorbable hemostatic system, which comprised PerClot granules and a delivery system for surgical use. Baxter International agreed to buy PerClot from Artivion in 2021. In 2023, after final FDA approval of the product, the purchase was completed.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
AORT Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$29.85
Kapitalizacja Rynkowa
$1.49B
P/E (TTM)
144.0
EPS (TTM)
$0.21
Przychody (TTM)
$441M
Stopa dywidendy
—
ROE
2.2%
D/E Dług/Kapitał
0.5
Zakres 52 tyg.
$19 – $48
AORT Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$441M
2016-12-31
→
2025-12-31
EPS
$0.21
2016-12-31
→
2025-12-31
Wolny przepływ pieniężny
$839.0K
2016-12-31
→
2025-12-31
Marże
2.2%
2016-12-31
→
2025-12-31
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
AORT
Mediana porównawcza
P/E (TTM)
144.0
38.5
P/S (TTM)
3.4
2.5
P/B
3.3
4.8
EV / EBITDA
29.2
—
Price / FCF (Cena / FCF)
1778.3
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
AORT
Mediana porównawcza
Gross Margin (Marża brutto)
64.4%
58.7%
Operating Margin (Marża Operacyjna)
7.6%
—
Net Profit Margin (Marża Zysku Netto)
2.2%
-12.6%
ROA
1.2%
-11.8%
ROE
2.2%
-37.7%
ROIC
3.4%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
AORT
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
0.5
25.5
Current Ratio (Wskaźnik bieżący)
3.5
3.5
Quick Ratio (Wskaźnik Szybkości)
1.5
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
AORT
Mediana porównawcza
Revenue YoY (Przychody R/R)
13.6%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
12.0%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
11.8%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
AORT
Mediana porównawcza
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
Stopa Dywidendy
—
Wskaźnik Wypłaty Dywidendy
—
CAGR dywidendy 5-letni
—
| Data ex-dywidendy | Kwota |
|---|---|
| 9 grudnia 2015 | $0,0300 |
| 9 września 2015 | $0,0300 |
| 10 czerwca 2015 | $0,0300 |
| 11 marca 2015 | $0,0300 |
| 10 grudnia 2014 | $0,0300 |
| 10 września 2014 | $0,0300 |
| 11 czerwca 2014 | $0,0300 |
| 12 marca 2014 | $0,0280 |
| 11 grudnia 2013 | $0,0280 |
| 11 września 2013 | $0,0280 |
| 12 czerwca 2013 | $0,0280 |
| 12 marca 2013 | $0,0250 |
| 12 grudnia 2012 | $0,0250 |
| 12 września 2012 | $0,0250 |
AORT Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
14 analityków
- Mocne kupno 5 35,7%
- Kup 8 57,1%
- Trzymaj 1 7,1%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
8 analityków · 2026-08-18
Mediana
$42.00
← Poniżej wszystkich celów
$29.85
Niski
$38.00
Wysoki
$48.00
Średni cel
$42.00
+40,7%
Średnia cel
$42.15
+41,2%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.02%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.28 | $0.01 | -0.29% |
| 31 marca 2026 | $0.03 | $0.05 | -0.02% |
| 31 grudnia 2025 | $0.05 | $0.08 | -0.03% |
| 30 września 2025 | $0.06 | $0.02 | 0.04% |
| 30 czerwca 2025 | $0.08 | $-0.00 | 0.08% |
| 31 marca 2025 | $-0.01 | $-0.12 | 0.11% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| AORT | $2.25B | 217.2 | 13.6% | 2.2% | 2.2% | 64.4% |
| KMTS | $1.21B | -8.5 | 59.0% | -138.4% | -62.1% | 51.4% |
| CNMD | $1.27B | 26.9 | 5.2% | 3.4% | 4.6% | 54.6% |
| ENOV | $1.52B | -1.3 | 6.7% | -52.7% | -58.5% | 59.8% |
| ATEC | $3.16B | -21.9 | 24.9% | -18.8% | -792.1% | 69.6% |
| IART | — | -1.8 | 1.5% | -31.6% | -49.6% | — |
| ASST | — | -0.1 | 1217.5% | — | — | — |
| PRCT | $1.77B | -18.3 | 37.2% | -31.0% | -25.4% | 63.7% |
| KMTS | $1.21B | -8.5 | 59.0% | -138.4% | -62.1% | 51.4% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 18
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $441M | $389M | $354M | $314M | $299M | $253M | $276M | $263M | $190M | $180M | $146M | $145M | |
| Cost of Revenue | $157M | $140M | $125M | $111M | $101M | $85M | $93M | $90M | $61M | $61M | $55M | $53M | |
| Gross Profit | $284M | $249M | $229M | $203M | $198M | $168M | $183M | $173M | $129M | $119M | $91M | $91M | |
| R&D Expense | $31M | $28M | $29M | $39M | $36M | $24M | $23M | $23M | $19M | $13M | $10M | $9M | |
| SG&A Expense | $226M | $181M | $209M | $157M | $170M | $141M | $143M | $141M | $101M | $92M | $75M | $74M | |
| Operating Expenses | $257M | $210M | $238M | $196M | $205M | $165M | $166M | $164M | $121M | $105M | $85M | $82M | |
| Operating Income | $34M | $39M | $6M | $6M | $8M | $2M | $17M | $9M | $8M | $22M | $5M | $9M | |
| Interest Expense | · | · | $25M | $18M | $17M | $17M | $15M | $16M | $5M | $3M | $62.0K | $175.0K | |
| Interest Income | $763.0K | $1M | $1M | $147.0K | $79.0K | $217.0K | $738.0K | $226.0K | $212.0K | $72.0K | $45.0K | $50.0K | |
| Other Non-op | $10M | $-10M | $-3M | $-3M | $-6M | $-3M | $-1M | $-141.0K | $260.0K | $-437.0K | $-484.0K | $-540.0K | |
| Pretax Income | $15M | $-8M | $-22M | $-15M | $-15M | $-17M | $2M | $-6M | $4M | $18M | $6M | $9M | |
| Income Tax | $5M | $6M | $9M | $4M | $7.0K | $-492.0K | $-76.0K | $-4M | $-143.0K | $8M | $2M | $1M | |
| Net Income | $10M | $-13M | $-31M | $-19M | $-15M | $-17M | $2M | $-3M | $4M | $11M | $4M | $7M | |
| EPS (Basic) | $0.22 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.33 | $0.14 | $0.26 | |
| EPS (Diluted) | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.32 | $0.14 | $0.25 | |
| Shares (Basic) | 45,335,000 | 41,676,000 | 40,743,000 | 40,032,000 | 38,983,000 | 37,861,000 | 37,118,000 | 36,412,000 | 33,008,000 | 31,855,000 | 27,744,000 | 27,379,000 | |
| Shares (Diluted) | 47,162,000 | 41,676,000 | 40,743,000 | 40,032,000 | 38,983,000 | 37,861,000 | 37,860,000 | 36,412,000 | 34,163,000 | 32,822,000 | 28,542,000 | 28,313,000 | |
| EBITDA | $56M | $63M | $29M | $29M | $32M | $23M | $35M | $27M | $18M | $30M | · | $15M |
Bilans 28
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $65M | $53M | $59M | $39M | $55M | $61M | $34M | $41M | $40M | $57M | $38M | $33M | |
| Receivables | $90M | $79M | $72M | $62M | $53M | $46M | $53M | $47M | $48M | $28M | $23M | $21M | |
| Inventory | $92M | $80M | $82M | $74M | $77M | $73M | $53M | $45M | $47M | $26M | $15M | $13M | |
| Prepaid Expense | $43M | $19M | $16M | $18M | $15M | $14M | $12M | $7M | $5M | $3M | $5M | $5M | |
| Current Assets | $358M | $290M | $281M | $247M | $248M | $235M | $187M | $179M | $179M | $147M | $110M | $106M | |
| PP&E (Net) | $65M | $36M | $38M | $39M | $38M | $33M | $32M | $31M | $34M | $19M | $11M | $12M | |
| PP&E (Gross) | · | · | · | $127M | $120M | $111M | $103M | $96M | $93M | $74M | $64M | $62M | |
| Accum. Depreciation | · | · | · | $88M | $82M | $78M | $71M | $65M | $60M | $55M | $53M | $50M | |
| Goodwill | $254M | $241M | $247M | $244M | $250M | $260M | $187M | $189M | $188M | $78M | $11M | $11M | |
| Intangibles | $124M | $128M | $143M | $151M | $167M | $186M | $115M | $118M | $130M | $1M | $1M | $2M | |
| Other Non-current Assets | $15M | $24M | $9M | $7M | $8M | $15M | $14M | $8M | $7M | $2M | $6M | $5M | |
| Total Assets | $885M | $789M | $792M | $763M | $793M | $789M | $606M | $571M | $590M | $316M | $181M | $176M | |
| Accounts Payable | $16M | $18M | $13M | $12M | $10M | $10M | $10M | $8M | $10M | $6M | $5M | $4M | |
| Accrued Liabilities | $16M | $12M | $10M | $12M | $8M | $7M | $7M | $7M | $12M | $5M | $3M | $3M | |
| Current Liabilities | $102M | $67M | $58M | $50M | $45M | $60M | $45M | $35M | $43M | $30M | $20M | $21M | |
| Capital Leases | $34M | $40M | $44M | $41M | $45M | $14M | $18M | $0 | $7M | $11.0K | · | · | |
| Deferred Tax | $24M | $20M | $22M | $24M | $29M | $35M | $26M | $27M | $30M | $7.0K | · | · | |
| Other Non-current Liabilities | $9M | $8M | $7M | $7M | $6M | $7M | $7M | $7M | $8M | $5M | $3M | $3M | |
| Total Liabilities | $437M | $513M | $511M | $478M | $492M | $461M | $320M | $296M | $313M | $107M | $26M | $27M | |
| Long-term Debt | $215M | $314M | $307M | $308M | $309M | $292M | $216M | $217M | $219M | $72M | · | · | |
| Total Debt | $215M | $314M | $307M | $308M | $309M | $292M | $216M | $217M | $219M | $72M | · | · | |
| Common Stock | $493.0K | $434.0K | $426.0K | $418.0K | $414.0K | $404.0K | $390.0K | $385.0K | $376.0K | $342.0K | $298.0K | $292.0K | |
| Retained Earnings | $-51M | $-61M | $-48M | $-17M | $2M | $20M | $37M | $35M | $38M | $34M | $23M | $23M | |
| Treasury Stock | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $13M | $12M | $11M | $9M | |
| AOCI | $-3M | $-25M | $-12M | $-22M | $-10M | $7M | $-9M | $-6M | $2M | $-429.0K | $-76.0K | $-121.0K | |
| Stockholders' Equity | $448M | $276M | $282M | $284M | $301M | $329M | $286M | $275M | $277M | $209M | $155M | $149M | |
| Liabilities + Equity | $885M | $789M | $792M | $763M | $793M | $789M | $606M | $571M | $590M | $316M | $181M | $176M | |
| Shares Outstanding | 49,330,000 | 43,432,000 | 42,569,000 | 41,830,000 | 41,397,000 | 40,394,000 | 39,018,000 | 38,463,000 | 37,618,000 | 34,230,000 | 29,766,000 | 29,229,000 |
Przepływy pieniężne 19
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $22M | $24M | $23M | $22M | $24M | $21M | $18M | $18M | $10M | $8M | $6M | $6M | |
| Stock-based Comp | $24M | $14M | $14M | $12M | $11M | $7M | $9M | $6M | $7M | $6M | $5M | $3M | |
| Deferred Tax | $37.0K | $-2M | $-1M | $-885.0K | $-6M | $816.0K | $-2M | $-6M | $-1M | $3M | $1M | $173.0K | |
| Amort. of Intangibles | $14M | $16M | $15M | $15M | $17M | $14M | $11M | $11M | $5M | $4M | $2M | $2M | |
| Other Non-cash | $-17M | $-1M | $13M | $-20M | $-17M | $611.0K | $-11M | $-5M | $-8M | $-8M | · | $-9M | |
| Operating Cash Flow | $40M | $22M | $19M | $-5M | $-3M | $12M | $16M | $10M | $11M | $20M | $11M | $8M | |
| CapEx | $39M | $11M | $10M | $11M | $13M | $7M | $8M | $6M | $7M | $6M | $3M | $4M | |
| Investing Cash Flow | $-42M | $-28M | $-502.0K | $-11M | $6M | $-73M | $-24M | $-7M | $-171M | $-79M | $-4M | · | |
| Debt Issued | $0 | $184M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $-210.0K | $-28M | $-3M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $13M | $6M | $4M | $3M | $4M | $2M | $5M | $4M | $3M | $2M | $2M | $3M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $6M | |
| Net Stock Activity | $13M | $6M | $4M | $3M | $4M | $2M | $5M | $4M | $3M | $2M | · | $-3M | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | $3M | $3M | |
| Financing Cash Flow | $11M | $2M | $865.0K | $-2M | $-12M | $94M | $-1M | $-3M | $143M | $73M | $-3M | · | |
| Net Change in Cash | $11M | $-5M | $20M | $-16M | $-7M | $28M | $-8M | $1M | $-17M | $14M | $4M | $-4M | |
| Taxes Paid | $3M | · | · | · | · | · | · | · | · | · | $145.0K | $3M | |
| Free Cash Flow | $839.0K | $11M | $11M | $-14M | $-16M | $5M | $8M | $4M | $4M | $14M | · | $4M | |
| Levered FCF | · | · | $-25M | $-38M | $-33M | $-11M | $-8M | $-3M | $-925.8K | $12M | · | · |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% | 66.3% | 66.3% | 65.8% | 67.8% | 65.9% | · | 63.1% | |
| Operating Margin | 7.6% | 10.0% | 1.6% | 2.0% | 2.7% | 0.96% | 6.2% | 3.5% | 4.2% | 12.1% | · | 6.1% | |
| Net Margin | 2.2% | -3.4% | -8.7% | -6.1% | -5.0% | -6.6% | 0.62% | -1.1% | 1.9% | 6.0% | · | 5.1% | |
| Pretax Margin | 3.4% | -1.9% | -6.1% | -4.8% | -5.0% | -6.8% | 0.60% | -2.4% | 1.9% | 10.2% | · | 6.0% | |
| EBITDA Margin | 12.7% | 16.2% | 8.1% | 9.1% | 10.7% | 9.1% | 12.8% | 10.4% | 9.3% | 16.7% | · | 10.3% | |
| ROA | 1.2% | -1.7% | -4.0% | -2.5% | -1.9% | -2.4% | 0.29% | -0.49% | 0.82% | 4.3% | · | 4.2% | |
| ROE | 2.2% | -4.6% | -11.1% | -7.1% | -4.9% | -5.1% | 0.61% | -1.0% | 1.5% | 5.9% | · | 5.0% | |
| ROIC | 3.4% | 11.7% | 1.4% | 1.3% | 1.3% | 0.38% | 3.6% | 0.84% | 1.7% | 4.5% | · | 5.0% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 4.3 | 4.9 | 5.0 | 5.5 | 3.9 | 4.1 | 5.2 | 4.2 | 4.9 | · | 5.1 | |
| Quick Ratio | 1.5 | 2.0 | 2.3 | 2.0 | 2.4 | 1.8 | 1.9 | 2.6 | 2.0 | 2.8 | · | 2.6 | |
| Debt / Equity | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | 0.3 | · | · | |
| LT Debt / Equity | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | 0.3 | · | · | |
| Interest Coverage | · | · | 0.2 | 0.3 | 0.5 | 0.1 | 1.1 | 0.6 | 1.6 | 7.3 | · | · |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.7 | · | 0.8 | |
| Inventory Turnover | 1.8 | 1.7 | 1.6 | 1.5 | 1.4 | 1.4 | 1.9 | 1.9 | 1.7 | 3.0 | · | 4.7 | |
| Receivables Turnover | 5.2 | 5.1 | 5.3 | 5.5 | 6.0 | 5.1 | 5.5 | 5.6 | 5.0 | 7.0 | · | 7.4 |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.6% | 9.8% | 12.8% | 5.0% | 18.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.0% | 9.1% | 11.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.8% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $441M | $389M | $354M | $314M | $299M | $253M | $276M | $263M | $190M | $180M | $146M | $145M | |
| Net Income TTM | $10M | $-13M | $-31M | $-19M | $-15M | $-17M | $2M | $-3M | $4M | $11M | $4M | $7M | |
| Market Cap | $2.25B | $1.24B | $761M | $507M | $842M | $954M | $1.06B | $1.09B | $720M | $656M | · | $331M | |
| Enterprise Value | $2.40B | $1.50B | $1.01B | $776M | $1.10B | $1.18B | $1.24B | $1.27B | $899M | $670M | · | · | |
| P/E | 217.2 | -89.3 | -23.8 | -25.2 | -53.6 | -53.7 | 541.8 | -354.8 | 174.1 | 59.8 | 77.0 | 45.3 | |
| P/S | 5.1 | 3.2 | 2.2 | 1.6 | 2.8 | 3.8 | 3.8 | 4.2 | 3.8 | 3.6 | · | 2.3 | |
| P/B | 5.0 | 4.5 | 2.7 | 1.8 | 2.8 | 2.9 | 3.7 | 4.0 | 2.6 | 3.1 | · | 2.2 | |
| P / Tangible Book | 31.9 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 56.4 | 55.8 | 40.4 | -98.4 | -325.9 | 77.1 | 66.8 | 110.5 | 66.7 | 33.2 | · | 40.8 | |
| P / FCF | 2681.7 | 112.4 | 66.8 | -35.8 | -53.7 | 189.2 | 136.3 | 266.6 | 172.7 | 48.5 | · | 87.0 | |
| EV / EBITDA | 42.7 | 23.8 | 35.0 | 27.1 | 34.2 | 51.1 | 35.0 | 46.2 | 50.8 | 22.2 | · | · | |
| EV / FCF | 2860.7 | 136.0 | 88.6 | -54.7 | -70.0 | 234.9 | 159.8 | 309.4 | 215.6 | 49.6 | · | · | |
| EV / Revenue | 5.4 | 3.9 | 2.9 | 2.5 | 3.7 | 4.7 | 4.5 | 4.8 | 4.7 | 3.7 | · | · | |
| Dividend Yield | · | · | · | · | · | · | · | · | · | · | · | 0.99% | |
| Earnings Yield | 0.46% | -1.1% | -4.2% | -4.0% | -1.9% | -1.9% | 0.18% | -0.28% | 0.57% | 1.7% | 1.3% | 2.2% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | · | 45.0% | |
| Annual Payout | · | · | · | · | · | · | · | · | · | · | $3M | $3M |
Rachunek zysków i strat 18
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $126M | $116M | $116M | $113M | $113M | $99M | $97M | $96M | $98M | $97M | $94M | $88M | $89M | $83M | $79M | $77M | |
| Cost of Revenue | $45M | $41M | $43M | $39M | $40M | $35M | $36M | $35M | $35M | $34M | $33M | $32M | $31M | $30M | $29M | $28M | |
| Gross Profit | $81M | $75M | $73M | $74M | $73M | $64M | $62M | $61M | $63M | $63M | $61M | $56M | $58M | $54M | $51M | $49M | |
| R&D Expense | $9M | $9M | $9M | $8M | $7M | $7M | $7M | $7M | $7M | $7M | $8M | $6M | $7M | $7M | $8M | $12M | |
| SG&A Expense | $80M | $61M | $57M | $57M | $58M | $55M | $51M | $50M | $49M | $31M | $50M | $51M | $57M | $50M | $38M | $41M | |
| Operating Expenses | $89M | $70M | $66M | $65M | $65M | $61M | $59M | $57M | $57M | $38M | $58M | $58M | $65M | $58M | $47M | $53M | |
| Operating Income | $-8M | $6M | $11M | $13M | $8M | $2M | $3M | $4M | $7M | $25M | $3M | $-1M | $8M | $-4M | $4M | $-4M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $8M | · | $7M | $6M | $6M | · | $5M | |
| Interest Income | $367.0K | $205.0K | $311.0K | $240.0K | $68.0K | $144.0K | $374.0K | $366.0K | $353.0K | $374.0K | $398.0K | $339.0K | $265.0K | $75.0K | $61.0K | $40.0K | |
| Other Non-op | $4M | $-286.0K | $1M | $399.0K | $5M | $3M | $-10M | $2M | $-983.0K | $-1M | $2M | $-2M | $-4M | $963.0K | $4M | $-4M | |
| Pretax Income | $-12M | $339.0K | $7M | $7M | $3M | $-2M | $-17M | $-1M | $-2M | $13M | $-591.0K | $-9M | $-3M | $-9M | $3M | $-13M | |
| Income Tax | $2M | $-1M | $4M | $554.0K | $2M | $-2M | $-119.0K | $1M | $-306.0K | $5M | $3M | $382.0K | $725.0K | $5M | $1M | $1M | |
| Net Income | $-14M | $1M | $2M | $7M | $1M | $-505.0K | $-16M | $-2M | $-2M | $8M | $-4M | $-10M | $-3M | $-14M | $2M | $-14M | |
| EPS (Basic) | $-0.28 | $0.03 | $0.06 | $0.14 | $0.03 | $-0.01 | $-0.40 | $-0.05 | $-0.05 | $0.18 | $-0.10 | $-0.24 | $-0.08 | $-0.33 | $0.05 | $-0.34 | |
| EPS (Diluted) | $-0.28 | $0.03 | $0.06 | $0.13 | $0.03 | $-0.01 | $-0.40 | $-0.05 | $-0.05 | $0.18 | $-0.10 | $-0.24 | $-0.08 | $-0.33 | $0.05 | $-0.34 | |
| Shares (Basic) | 48,541,000 | 48,074,000 | -88,426,000 | 47,233,000 | 44,296,000 | 42,232,000 | -83,141,000 | 41,844,000 | 41,683,000 | 41,290,000 | -81,325,000 | 40,881,000 | 40,755,000 | 40,432,000 | -79,964,000 | 40,115,000 | |
| Shares (Diluted) | 48,541,000 | 49,731,000 | -89,223,000 | 48,775,000 | 45,378,000 | 42,232,000 | -89,737,000 | 41,844,000 | 41,683,000 | 47,886,000 | -81,325,000 | 40,881,000 | 40,755,000 | 40,432,000 | -79,964,000 | 40,115,000 | |
| EBITDA | $-8M | $12M | · | $13M | $8M | $8M | · | $4M | $7M | $31M | · | $-1M | $8M | $2M | · | $-4M |
Bilans 26
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $77M | $56M | $65M | $73M | $53M | $38M | $53M | $56M | $55M | $51M | · | $53M | $49M | $31M | · | $38M | |
| Receivables | $98M | $92M | $90M | $88M | $91M | $88M | $79M | $76M | $74M | $74M | · | $64M | $65M | $63M | · | $57M | |
| Inventory | $103M | $98M | $92M | $91M | $87M | $82M | $80M | $84M | $81M | $82M | · | $79M | $78M | $76M | · | $73M | |
| Prepaid Expense | $27M | $45M | $43M | $22M | $25M | $20M | $19M | $19M | $20M | $17M | · | $17M | $19M | $20M | · | $17M | |
| Current Assets | $371M | $358M | $358M | $337M | $319M | $287M | $290M | $288M | $285M | $277M | · | $267M | $264M | $241M | · | $238M | |
| PP&E (Net) | $74M | $68M | $65M | $41M | $40M | $38M | $36M | $38M | $37M | $38M | · | $37M | $38M | $39M | · | $36M | |
| Goodwill | $350M | $252M | $254M | $254M | $254M | $245M | $241M | $249M | $244M | $245M | $247M | $243M | $246M | $246M | $244M | $235M | |
| Intangibles | $149M | $120M | $124M | $126M | $129M | $128M | $128M | $135M | $135M | $138M | · | $143M | $147M | $150M | · | $148M | |
| Other Non-current Assets | $15M | $16M | $15M | $29M | $27M | $25M | $24M | $21M | $14M | $13M | · | $8M | $8M | $8M | · | $7M | |
| Total Assets | $1.07B | $883M | $885M | $858M | $838M | $791M | $789M | $803M | $790M | $784M | · | $775M | $778M | $757M | · | $743M | |
| Accounts Payable | $21M | $18M | $16M | $16M | $19M | $12M | $18M | $11M | $12M | $10M | · | $11M | $10M | $9M | · | $11M | |
| Accrued Liabilities | $16M | $17M | $16M | $12M | $11M | $12M | $12M | $16M | $16M | $16M | · | $10M | $10M | $10M | · | $10M | |
| Current Liabilities | $107M | $93M | $102M | $86M | $67M | $52M | $67M | $153M | $51M | $46M | · | $55M | $56M | $44M | · | $46M | |
| Capital Leases | $36M | $34M | $34M | $38M | $39M | $39M | $40M | $41M | $42M | $43M | · | $43M | $40M | $41M | · | $41M | |
| Deferred Tax | $26M | $28M | $24M | $22M | $23M | $22M | $20M | $19M | $22M | $22M | · | $20M | $19M | $24M | · | $34M | |
| Other Non-current Liabilities | $9M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $8M | $8M | · | $8M | $7M | $7M | · | $7M | |
| Total Liabilities | $626M | $433M | $437M | $419M | $418M | $497M | $513M | $498M | $494M | $489M | · | $503M | $495M | $477M | · | $488M | |
| Long-term Debt | $363M | $215M | $215M | $215M | $216M | $315M | $314M | $314M | $314M | $313M | · | $307M | $308M | $308M | · | $308M | |
| Total Debt | $363M | $215M | · | $215M | $216M | $315M | · | $314M | $314M | $313M | · | $307M | $308M | $308M | · | $308M | |
| Common Stock | $502.0K | $500.0K | $493.0K | $488.0K | $486.0K | $442.0K | $434.0K | $434.0K | $433.0K | $432.0K | · | $425.0K | $424.0K | $424.0K | · | $418.0K | |
| Retained Earnings | $-64M | $-50M | $-51M | $-54M | $-60M | $-62M | $-61M | $-45M | $-42M | $-40M | · | $-44M | $-34M | $-31M | · | $-19M | |
| Treasury Stock | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | · | $15M | $15M | $15M | · | $15M | |
| AOCI | $-12M | $-12M | $-3M | $-2M | $-3M | $-19M | $-25M | $-10M | $-16M | $-14M | · | $-21M | $-16M | $-18M | · | $-45M | |
| Stockholders' Equity | $446M | $450M | $448M | $439M | $420M | $294M | $276M | $305M | $295M | $295M | $282M | $272M | $283M | $280M | $284M | $255M | |
| Liabilities + Equity | $1.07B | $883M | $885M | $858M | $838M | $791M | $789M | $803M | $790M | $784M | · | $775M | $778M | $757M | · | $743M | |
| Shares Outstanding | 50,179,000 | 49,983,000 | 49,330,000 | 48,862,000 | 48,592,000 | 44,190,000 | 43,432,000 | 43,392,000 | · | · | 42,569,000 | 42,537,000 | 42,443,000 | 42,366,000 | 41,830,000 | 41,816,000 |
Przepływy pieniężne 16
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7M | $6M | $6M | $6M | $6M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $6M | |
| Stock-based Comp | $8M | $8M | $4M | $6M | $6M | $8M | $3M | $4M | $4M | $3M | $4M | $3M | $4M | $3M | $3M | $3M | |
| Deferred Tax | · | · | · | · | · | · | $3M | · | · | · | $6M | · | · | · | · | · | |
| Amort. of Intangibles | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Other Non-cash | · | $-15M | · | · | · | $-30M | · | · | · | $-22M | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-1M | $1M | $20M | $22M | $15M | $-17M | $10M | $11M | $6M | $-5M | $11M | $7M | $7M | $-6M | $-217.0K | $4M | |
| CapEx | $11M | $8M | $28M | $5M | $3M | $4M | $1M | $4M | $3M | $4M | $3M | $3M | $3M | $3M | $4M | $3M | |
| Investing Cash Flow | $-129M | $-11M | $-31M | $-5M | $-3M | $-4M | $-11M | $-11M | $-3M | $-4M | $-3M | $-2M | $7M | $-3M | $-3M | $-3M | |
| Debt Issued | · | · | $0 | $0 | $0 | $0 | $-6M | $160M | $160M | $190M | $0 | $0 | $0 | $0 | · | · | |
| Net Debt Issued | · | $0 | · | · | · | $-66.0K | · | · | · | $-182M | · | · | · | · | · | · | |
| Stock Issued | $1M | $1M | $3M | $5M | $278.0K | $4M | $443.0K | $2M | $59.0K | $4M | $488.0K | $886.0K | $0 | $3M | $24.0K | $1M | |
| Net Stock Activity | · | $1M | · | · | · | $4M | · | · | · | $4M | · | · | · | $3M | · | · | |
| Financing Cash Flow | $152M | $463.0K | $2M | $2M | $3M | $4M | $174.0K | $1M | $-181.0K | $737.0K | $-2M | $-909.0K | $2M | $1M | $-859.0K | $252.0K | |
| Net Change in Cash | $22M | $-9M | $-9M | $20M | $16M | $-16M | $-3M | $1M | $4M | $-8M | $5M | $5M | $18M | $-9M | $2M | $-3M | |
| Free Cash Flow | · | $-7M | · | · | · | $-21M | · | · | · | $-9M | · | · | · | $-8M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-14M | · | · | · | $-18M | · | · |
Rentowność 8
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.0% | 64.8% | · | 65.6% | 64.7% | 64.2% | · | 63.7% | 64.6% | 64.6% | · | 64.0% | 65.1% | 64.5% | · | 63.4% | |
| Operating Margin | -6.7% | 5.0% | · | 11.1% | 7.4% | 2.2% | · | 4.6% | 6.6% | 26.0% | · | -1.4% | 8.6% | -4.6% | · | -5.3% | |
| Net Margin | -10.7% | 1.2% | · | 5.7% | 1.2% | -0.51% | · | -2.4% | -2.2% | 7.7% | · | -11.2% | -3.8% | -16.3% | · | -17.8% | |
| Pretax Margin | -9.3% | 0.29% | · | 6.2% | 3.1% | -2.3% | · | -1.3% | -2.5% | 13.1% | · | -10.7% | -3.0% | -10.7% | · | -16.3% | |
| EBITDA Margin | -6.7% | 10.4% | · | 11.1% | 7.4% | 7.7% | · | 4.6% | 6.6% | 32.0% | · | -1.4% | 8.6% | 2.2% | · | -5.3% | |
| ROA | -1.4% | 0.17% | · | 0.78% | 0.17% | -0.06% | · | -0.29% | -0.27% | 0.98% | · | -1.3% | -0.44% | -1.8% | · | -1.8% | |
| ROE | -3.1% | 0.38% | · | 1.8% | 0.38% | -0.17% | · | -0.79% | -0.73% | 2.6% | · | -3.7% | -1.2% | -4.7% | · | -4.8% | |
| ROIC | -1.2% | 3.6% | · | 1.8% | 0.51% | 0.08% | · | 1.3% | 0.93% | 2.5% | · | -0.22% | 1.7% | -1.0% | · | -0.80% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 3.9 | · | 3.9 | 4.8 | 5.5 | · | 1.9 | 5.6 | 6.0 | · | 4.9 | 4.7 | 5.5 | · | 5.2 | |
| Quick Ratio | 1.6 | 1.6 | · | 1.9 | 2.2 | 2.4 | · | 0.9 | 2.5 | 2.7 | · | 2.1 | 2.0 | 2.1 | · | 2.1 | |
| Debt / Equity | 0.8 | 0.5 | · | 0.5 | 0.5 | 1.1 | · | 1.0 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | |
| LT Debt / Equity | 0.8 | 0.5 | · | 0.5 | 0.5 | 1.1 | · | 0.7 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 3.2 | · | -0.2 | 1.2 | -0.6 | · | -0.9 |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.4 | 1.4 | 1.2 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.4 | · | 1.4 |
Wycena (TTM) 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $468M | $442M | · | $421M | $406M | $390M | · | $379M | $373M | $358M | · | $337M | $330M | $318M | · | $307M | |
| Net Income TTM | $-4M | $9M | · | $5M | $-4M | $3M | · | $-7M | $-8M | $-19M | · | $-40M | $-35M | $-35M | · | $-11M | |
| Market Cap | $1.13B | $1.83B | · | $2.07B | $1.51B | $1.09B | · | $1.16B | · | · | · | $645M | $730M | $555M | · | $579M | |
| Enterprise Value | $1.41B | $1.99B | · | $2.21B | $1.67B | $1.36B | · | $1.41B | · | · | · | $899M | $988M | $832M | · | $849M | |
| P/E | -249.7 | 203.4 | · | 423.4 | -388.8 | 351.1 | · | -166.4 | -135.0 | -45.0 | · | -15.3 | -20.0 | -15.2 | · | -51.3 | |
| P/S | 2.4 | 4.1 | · | 4.9 | 3.7 | 2.8 | · | 3.0 | · | · | · | 1.9 | 2.2 | 1.7 | · | 1.9 | |
| P/B | 2.5 | 4.1 | · | 4.7 | 3.6 | 3.7 | · | 3.8 | · | · | · | 2.4 | 2.6 | 2.0 | · | 2.3 | |
| P / Tangible Book | · | 23.2 | · | 35.5 | 41.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | 1586.1 | · | · | · | -64.1 | · | · | · | · | · | · | · | -90.2 | · | · | |
| P / FCF | · | -267.2 | · | · | · | -52.8 | · | · | · | · | · | · | · | -66.1 | · | · | |
| EV / EBITDA | -169.0 | 164.1 | · | 176.3 | 199.6 | 179.6 | · | 322.1 | · | · | · | -722.5 | 128.8 | 444.3 | · | -206.9 | |
| EV / FCF | · | -290.5 | · | · | · | -66.2 | · | · | · | · | · | · | · | -99.2 | · | · | |
| EV / Revenue | 3.0 | 4.5 | · | 5.2 | 4.1 | 3.5 | · | 3.7 | · | · | · | 2.7 | 3.0 | 2.6 | · | 2.8 | |
| Earnings Yield | -0.40% | 0.49% | · | 0.24% | -0.26% | 0.28% | · | -0.60% | -0.74% | -2.2% | · | -6.5% | -5.0% | -6.6% | · | -1.9% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $441M | $389M | $354M | $314M | $299M |
| Marża Brutto % | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% |
| Marża Operacyjna % | 7.6% | 10.0% | 1.6% | 2.0% | 2.7% |
| Zysk netto | $10M | $-13M | $-31M | $-19M | $-15M |
| Rozwodniony EPS | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 |
| Wskaźnik bieżący | 3.5 | 4.3 | 4.9 | 5.0 | 5.5 |
| Wskaźnik Szybkości | 1.5 | 2.0 | 2.3 | 2.0 | 2.4 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $839.0K | $11M | $11M | $-14M | $-16M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 216 emitentów · $724.0M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 42 (+1 vs poprzedni kw.) | 65 (+29 vs poprzedni kw.) | 80 (-7 vs poprzedni kw.) | 47 (-16 vs poprzedni kw.) | +2.1M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $71 566 000 | 3 184 974 | 9,88% | Akcje |
| Juniper Investment Company, LLC | $45 386 816 | 2 019 885 | 6,27% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $45 043 789 | 2 004 619 | 6,22% | Akcje |
| FMR LLC | $41 871 497 | 1 863 440 | 5,78% | Akcje |
| STATE STREET CORP | $41 750 406 | 1 858 051 | 5,77% | Akcje |
| Ophir Asset Management Pty Ltd | $40 446 180 | 1 800 008 | 5,59% | Akcje |
| PERCEPTIVE ADVISORS LLC | $39 036 906 | 1 737 290 | 5,39% | Akcje |
| Conestoga Capital Advisors, LLC | $36 484 539 | 1 623 700 | 5,04% | Akcje |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $23 011 325 | 1 024 091 | 3,18% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $22 205 281 | 988 219 | 3,07% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $21 427 261 | 953 365 | 2,96% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $20 062 856 | 892 873 | 2,77% | Akcje |
| CITADEL ADVISORS LLC | $17 701 821 | 787 798 | 2,44% | Akcje |
| YARGER WEALTH STRATEGIES, LLC | $15 278 432 | 634 223 | 2,11% | Akcje |
| ROYCE & ASSOCIATES LP | $14 364 667 | 639 282 | 1,98% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $11 702 264 | 520 795 | 1,62% | Akcje |
| Qube Research & Technologies Ltd | $10 704 820 | 476 405 | 1,48% | Akcje |
| FRED ALGER MANAGEMENT, LLC | $10 406 104 | 463 111 | 1,44% | Akcje |
| TWO SIGMA ADVISERS, LP | $9 974 907 | 218 700 | 1,38% | Akcje |
| D. E. Shaw & Co., Inc. | $9 846 714 | 438 216 | 1,36% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9 183 579 | 408 704 | 1,27% | Akcje |
| Toroso Investments, LLC | $9 018 146 | 197 723 | 1,25% | Akcje |
| Soleus Capital Management, L.P. | $8 718 360 | 388 000 | 1,20% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $8 702 159 | 387 279 | 1,20% | Akcje |
| Balyasny Asset Management L.P. | $8 584 686 | 382 051 | 1,19% | Akcje |
| GOLDMAN SACHS GROUP INC | $7 733 095 | 344 152 | 1,07% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $6 978 103 | 310 552 | 0,96% | Akcje |
| KENNEDY CAPITAL MANAGEMENT LLC | $6 611 371 | 294 231 | 0,91% | Akcje |
| UBS Group AG | $6 026 544 | 268 204 | 0,83% | Akcje |
| WASATCH ADVISORS LP | $5 726 929 | 156 388 | 0,79% | Akcje |
| Quantinno Capital Management LP | $4 497 191 | 200 142 | 0,62% | Akcje |
| AMERIPRISE FINANCIAL INC | $4 347 068 | 193 461 | 0,60% | Akcje |
| FIFTH THIRD BANCORP | $4 170 912 | 185 621 | 0,58% | Akcje |
| ORBIMED ADVISORS LLC | $3 932 250 | 175 000 | 0,54% | Akcje |
| Corient Private Wealth LP | $3 578 618 | 159 262 | 0,49% | Akcje |
| Public Sector Pension Investment Board | $3 298 304 | 146 787 | 0,46% | Akcje |
| Parkman Healthcare Partners LLC | $3 121 982 | 138 940 | 0,43% | Akcje |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $2 879 149 | 128 133 | 0,40% | Akcje |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $2 857 263 | 127 159 | 0,39% | Akcje |
| Summit Creek Advisors LLC | $2 704 354 | 120 354 | 0,37% | Akcje |
| CONNORS INVESTOR SERVICES INC | $2 700 445 | 120 180 | 0,37% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $2 693 816 | 119 885 | 0,37% | Akcje |
| Bank of New York Mellon Corp | $2 522 415 | 112 257 | 0,35% | Akcje |
| RHUMBLINE ADVISERS | $2 373 280 | 105 621 | 0,33% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 303 872 | 102 531 | 0,32% | Akcje |
| XTX Topco Ltd | $2 173 905 | 96 747 | 0,30% | Akcje |
| Swiss National Bank | $1 914 444 | 85 200 | 0,26% | Akcje |
| BANK OF AMERICA CORP /DE/ | $1 912 535 | 85 115 | 0,26% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1 875 420 | 51 213 | 0,26% | Akcje |
| LAZARD ASSET MANAGEMENT LLC | $1 875 301 | 83 458 | 0,26% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $1 524 073 | 67 827 | 0,21% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $1 522 477 | 41 575 | 0,21% | Akcje |
| Legal & General Group Plc | $1 468 954 | 65 374 | 0,20% | Akcje |
| CITIGROUP INC | $1 425 856 | 63 456 | 0,20% | Akcje |
| Squarepoint Ops LLC | $1 424 238 | 63 384 | 0,20% | Akcje |
| Russell Investments Group, Ltd. | $1 303 125 | 57 994 | 0,18% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $1 193 157 | 53 100 | 0,16% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $1 117 972 | 49 754 | 0,15% | Akcje |
| Sterling Capital Management LLC | $1 098 918 | 48 906 | 0,15% | Akcje |
| Sio Capital Management, LLC | $1 089 368 | 48 481 | 0,15% | Akcje |
| BOOTHBAY FUND MANAGEMENT, LLC | $1 010 521 | 44 972 | 0,14% | Akcje |
| PRUDENTIAL FINANCIAL INC | $995 219 | 44 291 | 0,14% | Akcje |
| WELLS FARGO & COMPANY/MN | $937 314 | 41 714 | 0,13% | Akcje |
| VANGUARD GROUP INC | $898 699 | 19 704 | 0,12% | Akcje |
| FIRST TRUST ADVISORS LP | $857 657 | 38 169 | 0,12% | Akcje |
| BlackRock, Inc. | $789 461 | 35 134 | 0,11% | Akcje |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $738 274 | 32 856 | 0,10% | Akcje |
| Verition Fund Management LLC | $729 399 | 32 461 | 0,10% | Akcje |
| Aquatic Capital Management LLC | $712 771 | 31 721 | 0,10% | Akcje |
| Jain Global LLC | $680 908 | 30 303 | 0,09% | Akcje |
| JONES FINANCIAL COMPANIES LLLP | $662 072 | 28 042 | 0,09% | Akcje |
| Brevan Howard Capital Management LP | $652 461 | 29 037 | 0,09% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $634 193 | 28 224 | 0,09% | Akcje |
| JANUS HENDERSON GROUP PLC | $623 335 | 17 038 | 0,09% | Akcje |
| MetLife Investment Management, LLC | $601 050 | 26 749 | 0,08% | Akcje |
| Y-Intercept (Hong Kong) Ltd | $600 735 | 26 735 | 0,08% | Akcje |
| Mariner, LLC | $570 520 | 25 390 | 0,08% | Akcje |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $561 750 | 25 000 | 0,08% | Akcje |
| Illinois Municipal Retirement Fund | $545 010 | 24 255 | 0,08% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $516 855 | 23 002 | 0,07% | Akcje |
| Walleye Capital LLC | $490 408 | 21 825 | 0,07% | Akcje |
| Penn Capital Management Company, LLC | $489 689 | 21 793 | 0,07% | Akcje |
| ALLSTATE CORP | $483 240 | 21 506 | 0,07% | Akcje |
| EXCHANGE TRADED CONCEPTS, LLC | $476 948 | 21 226 | 0,07% | Akcje |
| MORGAN STANLEY | $476 588 | 21 210 | 0,07% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $473 241 | 21 061 | 0,07% | Akcje |
| Louisiana State Employees Retirement System | $420 189 | 18 700 | 0,06% | Akcje |
| Invesco Ltd. | $409 628 | 18 230 | 0,06% | Akcje |
| DARK FOREST CAPITAL MANAGEMENT LP | $402 123 | 17 896 | 0,06% | Akcje |
| Vanguard Global Advisers, LLC | $371 384 | 16 528 | 0,05% | Akcje |
| Freestone Grove Partners LP | $328 219 | 14 607 | 0,05% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $324 287 | 14 432 | 0,04% | Akcje |
| JOHNSON INVESTMENT COUNSEL INC | $307 008 | 13 663 | 0,04% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $303 053 | 13 487 | 0,04% | Akcje |
| DIKER MANAGEMENT LLC | $303 000 | 13 500 | 0,04% | Akcje |
| OPPENHEIMER ASSET MANAGEMENT INC. | $284 672 | 12 669 | 0,04% | Akcje |
| GUGGENHEIM CAPITAL LLC | $283 302 | 12 608 | 0,04% | Akcje |
| ELEVATION POINT WEALTH PARTNERS, LLC | $263 303 | 11 718 | 0,04% | Akcje |
| Vestmark Advisory Solutions, Inc. | $263 303 | 11 718 | 0,04% | Akcje |
| ARIZONA STATE RETIREMENT SYSTEM | $263 101 | 11 709 | 0,04% | Akcje |
Insiderzy spółki 49 insiderów · 27 dyrektorzy generalni · 15 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| James P Mackin | President & CEO | 6 marca 2025 M | 865 283 | 0 | 0 | $0 |
| David Ashley Lee | Executive VP, COO & CFO | 2 marca 2023 S | 347 217 | 0 | 0 | $0 |
| Marshall S. Stanton | SVP, Clinical & MD Affair | 17 czerwca 2025 S | 64 200 | 0 | 0 | $0 |
| John E Davis | Chief Commercial Officer | 11 marca 2025 M | 208 778 | 0 | 0 | $0 |
| Amy Horton | VP, Chief Accounting Officer | 6 marca 2025 S | 146 651 | 0 | 0 | $0 |
| Matthew A Getz | VP, Human Resources | 16 sierpnia 2024 S | 34 116 | 0 | 0 | $0 |
| Florian Tyrs | VP, Global Operations | 27 lutego 2024 S | 21 558 | 0 | 0 | $0 |
| Rochelle L. Maney | VP, Quality | 26 lutego 2024 S | 44 518 | 0 | 0 | $0 |
| Robert C Thomson | VP Research & Development | 23 lutego 2024 A | 13 291 | 0 | 0 | $0 |
| Dennis B Maier | SVP, Operations | 6 czerwca 2023 S | 34 724 | 0 | 0 | $0 |
| Franz Peter Barthold | VP, Research & Development | 8 listopada 2022 A | 32 516 | 0 | 0 | $0 |
| Scott B Capps | VP, Clinical Research | 12 marca 2021 F | 153 203 | 0 | 0 | $0 |
| James M Mcdermid | SVP, CHRO | 14 marca 2019 F | 30 806 | 0 | 0 | $0 |
| Sherry M Saurini | VP, Quality | 14 marca 2019 F | 25 084 | 0 | 0 | $0 |
| William Robert Matthews | Senior VP, Operations, Quality | 5 marca 2018 F | 39 883 | 0 | 0 | $0 |
| David C Gale | VP, Research & Development | 16 listopada 2017 M | 77 135 | 0 | 0 | $0 |
| Steven G Anderson | Former Executive Chairman | 9 kwietnia 2015 F | 1 271 846 | 0 | 0 | $0 |
| Bruce G. Anderson | VP, US Sales &Global Marketing | 7 marca 2015 F | 42 106 | 0 | 0 | $0 |
| FRONK DAVID | VP, Regulatory Affairs | 7 marca 2015 F | 110 559 | 0 | 0 | $0 |
| David P. Lang | VP, Int'l Sales & Marketing | 26 lutego 2015 A | 73 441 | 0 | 0 | $0 |
| Jeffrey W Burris | Vice President & Gen. Counsel | 15 sierpnia 2014 M | 95 221 | 0 | 0 | $0 |
| Gerald B Seery | Sr. VP, Sales and Marketing | 30 listopada 2012 S | 71 999 | 0 | 0 | $0 |
| Albert E Heacox | Sr. VP Research and Devl | 31 grudnia 2011 F | 110 144 | 0 | 0 | $0 |
| Philip A Theodore | VP, General Counsel | 4 września 2007 A | 23 100 | 0 | 0 | $0 |
| Sidney B Ashmore | Vice President of Marketing | 18 stycznia 2006 M | 42 728 | 0 | 0 | $0 |
| Kirby S Black | Sr. Vice President, R&D | 21 września 2004 M | 55 131 | 0 | 0 | $0 |
| Vander James C Wyk | VP - Product Integrity | 14 września 2004 M | 36 165 | 0 | 0 | $0 |
| Anthony B. Semedo | Dyrektor | 2 czerwca 2026 J | 6 325 | 0 | 0 | $0 |
| Elizabeth A Hoff | Dyrektor | 22 maja 2025 A | 31 389 | 0 | 0 | $0 |
| Marna P Borgstrom | Dyrektor | 22 maja 2025 A | 49 088 | 0 | 0 | $0 |
| Jon W Salveson | Dyrektor | 22 maja 2025 A | 129 840 | 0 | 0 | $0 |
| Jeffrey H Burbank | Dyrektor | 22 maja 2025 A | 53 796 | 0 | 0 | $0 |
| Daniel J Bevevino | Dyrektor | 22 maja 2025 A | 150 061 | 0 | 0 | $0 |
| Bullock James | Dyrektor | 22 maja 2025 A | 68 647 | 0 | 0 | $0 |
| Thomas F Ackerman | Dyrektor | 22 maja 2025 A | 149 896 | 0 | 0 | $0 |
| Harvey Morgan | Dyrektor | 30 sierpnia 2021 G | 46 342 | 0 | 0 | $0 |
| Ronald D Mccall | Dyrektor | 25 sierpnia 2021 S | 121 768 | 0 | 0 | $0 |
| Elkins C Ronald | Dyrektor | 5 września 2018 S | 64 843 | 0 | 0 | $0 |
| James Benson | Dyrektor | 2 października 2017 S | 54 086 | 0 | 0 | $0 |
| John M Cook | Dyrektor | 9 czerwca 2009 M | 85 000 | 0 | 0 | $0 |
| LACY VIRGINIA C | Dyrektor | 24 kwietnia 2007 S | 255 280 | 0 | 0 | $0 |
| VAN DYNE BRUCE J MD | Dyrektor | 1 sierpnia 2006 A | 12 800 | 0 | 0 | $0 |
| OSS CAPITAL MANAGEMENT | Posiadacz 10% | 31 maja 2007 S | 1 918 000 | 0 | 0 | $0 |
| Lance A Berry | — | 14 sierpnia 2026 S | 210 112 | 0 | 1 | $-20 413 |
| Andrew M Green | — | 14 sierpnia 2026 S | 59 643 | 0 | 3 | $-928 248 |
| Jean F Holloway | — | 12 sierpnia 2026 S | 184 118 | 0 | 1 | $-27 835 |
| Michael S Simpson | — | 5 marca 2021 F | 33 698 | 0 | 0 | $0 |
| Thomas J Bogenschuetz | — | 5 maja 2020 A | 23 451 | 0 | 0 | $0 |
| Thomas J Lynch | — | 2 listopada 2004 A | 5 000 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 5 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Juniper Targeted Opportunity Fund, L.P., Juniper HF Investors II, LLC, Juniper Targeted Opportunities, L.P., Juniper Targeted Opportunity Investors, LLC, Juniper Multi-Strategy Fund, L.P., Juniper HF Investors, LLC, Juniper Investment Company, LLC, Alexis P. Michas, John A. Bartholdson ×2 zgłoszenia | 12 sierpnia 2025 | 4,00% | Aneks | — | SEC |
| CryoLife, Inc., CL Falcon, Inc. | 11 maja 2011 | — | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
| Michael A. Roth and Brian J. Stark, as joint filers pursuant to Rule 13d-1(k) | 10 lipca 2007 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 2 grudnia 2005 | — | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
| Niezgłoszona osoba raportująca | 18 marca 2005 | — | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 54 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| SAWS · ETF Series Solutions | 2,95% | 5 817 NS | 30 kwietnia 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,77% | 26 421 NS | 30 kwietnia 2026 | N-PORT |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0,25% | 21 547 NS | 31 maja 2026 | N-PORT |
| ESSC · Strategy Shares | 0,24% | 1 691 NS | 30 kwietnia 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,11% | 31 285 NS | 30 kwietnia 2026 | N-PORT |
| RSSL · Global X Funds | 0,05% | 18 968 NS | 30 kwietnia 2026 | N-PORT |
| PSC · Principal Exchange-Traded Funds | 0,04% | 44 339 NS | 30 czerwca 2026 | N-PORT |
| SAA · ProShares Trust | 0,04% | 505 NS | 31 maja 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,04% | 158 121 NS | 30 kwietnia 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,03% | 14 525 NS | 31 maja 2026 | N-PORT |
| EBIT · Harbor ETF Trust | 0,03% | 101 NS | 30 kwietnia 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,03% | 999 NS | 30 kwietnia 2026 | N-PORT |
| ITWO · ProShares Trust | 0,02% | 2 057 NS | 31 maja 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 18 392 NS | 30 kwietnia 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,02% | 2 917 NS | 30 kwietnia 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 200 917 NS | 31 maja 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 1 609 NS | 31 maja 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 1 624 NS | 31 maja 2026 | N-PORT |
| JSTC · Tidal Trust I | 0,01% | 1 526 NS | 31 maja 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 107 410 NS | 30 kwietnia 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 1 773 NS | 31 maja 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 3 861 NS | 30 kwietnia 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 41 NS | 31 maja 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 1 937 NS | 30 kwietnia 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 8 873 NS | 30 kwietnia 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 12 377 NS | 30 kwietnia 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 25 635 NS | 31 maja 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 636 NS | 30 kwietnia 2026 | N-PORT |
| EBI · RBB Fund Trust | 0,00% | 3 NS | 31 maja 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 lipca 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 lipca 2026 | Dziennie |
| VIOO · VANGUARD ADMIRAL FUNDS | — | — | 15 lipca 2026 | Dziennie |
| VIOG · VANGUARD ADMIRAL FUNDS | — | — | 30 lipca 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 lipca 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 lipca 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 lipca 2026 | Dziennie |
| IJR · iShares Trust | — | — | 10 sierpnia 2026 | Dziennie |
| IJT · iShares Trust | — | — | 17 sierpnia 2026 | Dziennie |
| ITOT · iShares Trust | — | — | 22 lipca 2026 | Dziennie |
| IWV · iShares Trust | — | — | 18 sierpnia 2026 | Dziennie |
| IWO · iShares Trust | — | — | 18 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | — | — | 18 sierpnia 2026 | Dziennie |
| IHI · iShares Trust | — | — | 17 sierpnia 2026 | Dziennie |
| XJR · iShares Trust | — | — | 18 sierpnia 2026 | Dziennie |
| XSMO · Invesco Exchange-Traded Fund Trust | — | — | 6 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 13 lipca 2026 | Dziennie |
| RZG · Invesco Exchange-Traded Fund Trust | — | — | 28 lipca 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | — | — | 20 lipca 2026 | Dziennie |
| ISCB · iShares Trust | — | — | 20 lipca 2026 | Dziennie |
| ISCG · iShares Trust | — | — | 21 lipca 2026 | Dziennie |